Viscus Biologics
PrivateLast Round
Grant
Oct 20, 2014
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Viscus Biologics is a biotechnology company that specializes in the development and manufacturing of extracellular matrix (ECM) biomaterials and medical devices for regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials, 3D Printing
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Viscus Biologics Comparables
Compare Viscus Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Integer Holdings Corporation | 78% | |
| Novex Innovations | 77% | |
| Stemmatters | 76% |
Viscus Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 20, 2014 |
Key People
Founding team and executive leadership
Viscus Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ohio Third Frontier Commission | Grant |
| Global Cardiovascular Innovation Center | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors increased 73% MoM.
- May 5, 2026
Grew 25% QoQ, from 12 to 15 employees.
Viscus Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Viscus Biologics's valuation, stock price, and market status.
Is Viscus Biologics a public or private company?
Viscus Biologics is a private company.
What is the current stock price of Viscus Biologics?
Viscus Biologics is a private company with no public stock price. No recent secondary market data is available.
How much is Viscus Biologics worth (valuation)?
Valuation information for Viscus Biologics is not publicly available.
Can I buy Viscus Biologics stock?
Viscus Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Viscus Biologics's last funding round?
Viscus Biologics's most recent funding round was Grant on October 20, 2014.
Who are the main investors in Viscus Biologics?
Key investors in Viscus Biologics include Ohio Third Frontier Commission, Global Cardiovascular Innovation Center.
Will Viscus Biologics IPO soon?
No public IPO plans have been announced for Viscus Biologics.
How can I track Viscus Biologics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Viscus Biologics's secondary market activity and sign up for updates.